カテゴリー： LP Information, 世界, 医療/バイオ

世界の解熱鎮痛薬市場予測 2021年-2026年

【英語タイトル】Global Antipyretic Analgesics Market Growth 2021-2026

LP Informationが出版した調査資料（LPI21MY9423）・商品コード：LPI21MY9423
・発行会社（調査会社）：LP Information
・発行日：2021年5月（※2024年版があります。お問い合わせください）
・ページ数：162
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後2-3営業日）
・調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
・産業分野：医薬品
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,660 ⇒換算￥541,680見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,490 ⇒換算￥812,520見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）USD7,320 ⇒換算￥1,083,360見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
LPインフォメーション社の「解熱鎮痛薬の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、パラセタモール、アスピリン、イブプロフェン、ナプロキセン、ジクロフェナク、オキサプロジン、デキシブプロフェン、その他など、用途別には、成人、子供などにセグメント区分してまとめました。解熱鎮痛薬のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。
・解熱鎮痛薬の世界市場概要（サマリー）
・解熱鎮痛薬の企業別販売量・売上
・解熱鎮痛薬の企業別市場シェア
・解熱鎮痛薬の世界市場規模 2016年-2021年：種類別（パラセタモール、アスピリン、イブプロフェン、ナプロキセン、ジクロフェナク、オキサプロジン、デキシブプロフェン、その他）
・解熱鎮痛薬の世界市場規模 2016年-2021年：用途別（成人、子供）
・解熱鎮痛薬の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど）
・解熱鎮痛薬のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）
・解熱鎮痛薬のヨーロッパ市場規模（ドイツ、フランス、イギリス、イタリア、ロシアなど）
・解熱鎮痛薬の中東・アフリカ市場（エジプト、南アフリカ、トルコ、GCC諸国など）
・解熱鎮痛薬市場の成長要因・課題・動向
・解熱鎮痛薬の世界市場予測 2021年-2026年
・解熱鎮痛薬の南北アメリカ市場予測（アメリカ、カナダ、メキシコなど）
・解熱鎮痛薬のアジア市場予測（日本、中国、韓国、インド、東南アジアなど）
・解熱鎮痛薬のヨーロッパ市場予測（ドイツ、フランス、イギリス、イタリア、ロシアなど）
・解熱鎮痛薬の中東・アフリカ市場予測（エジプト、南アフリカ、トルコ、GCC諸国など）
・解熱鎮痛薬の世界市場予測：種類別（パラセタモール、アスピリン、イブプロフェン、ナプロキセン、ジクロフェナク、オキサプロジン、デキシブプロフェン、その他）
・解熱鎮痛薬の世界市場予測：用途別（成人、子供）
・主要企業分析
【レポートの概要】

According to this latest study, the 2021 growth of Antipyretic Analgesics will have significant change from previous year. By the most conservative estimates of global Antipyretic Analgesics market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 2685.6 million in 2020. Over the next five years the Antipyretic Analgesics market will register a 1.2% CAGR in terms of revenue, the global market size will reach US$ 2821.8 million by 2026.

This report presents a comprehensive overview, market shares, and growth opportunities of Antipyretic Analgesics market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
Paracetamol
Aspirin
Ibuprofen
Naproxen
Diclofenac
Oxaprozin
Dexibuprofen
Others

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
Adults
Children

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
Mallinckrodt Pharmaceuticals
IOL
Anqiu Lu’an Pharmaceutical
Novacyl
BASF
Anhui BBCA Pharmaceuticals
Hubei Biocause
Xinhua Pharm
Granules India Limited
Huagang Pharm
Hebei Jiheng Pharmaceutical
Zhejiang Kangle Pharmaceutical
Hebei Jingye Medical Technology
MSPF

【レポートの目次】

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Antipyretic Analgesics Consumption 2016-2026
2.1.2 Antipyretic Analgesics Consumption CAGR by Region
2.2 Antipyretic Analgesics Segment by Type
2.2.1 Paracetamol
2.2.2 Aspirin
2.2.3 Ibuprofen
2.2.4 Naproxen
2.2.5 Diclofenac
2.2.6 Oxaprozin
2.2.7 Dexibuprofen
2.2.8 Others
2.3 Antipyretic Analgesics Sales by Type
2.3.1 Global Antipyretic Analgesics Sales Market Share by Type (2016-2021)
2.3.2 Global Antipyretic Analgesics Revenue and Market Share by Type (2016-2021)
2.3.3 Global Antipyretic Analgesics Sale Price by Type (2016-2021)
2.4 Antipyretic Analgesics Segment by Application
2.4.1 Adults
2.4.2 Children
2.5 Antipyretic Analgesics Sales by Application
2.5.1 Global Antipyretic Analgesics Sale Market Share by Application (2016-2021)
2.5.2 Global Antipyretic Analgesics Revenue and Market Share by Application (2016-2021)
2.5.3 Global Antipyretic Analgesics Sale Price by Application (2016-2021)

3 Global Antipyretic Analgesics by Company
3.1 Global Antipyretic Analgesics Sales Market Share by Company
3.1.1 Global Antipyretic Analgesics Sales by Company (2019-2021)
3.1.2 Global Antipyretic Analgesics Sales Market Share by Company (2019-2021)
3.2 Global Antipyretic Analgesics Revenue Market Share by Company
3.2.1 Global Antipyretic Analgesics Revenue by Company (2019-2021)
3.2.2 Global Antipyretic Analgesics Revenue Market Share by Company (2019-2021)
3.3 Global Antipyretic Analgesics Sale Price by Company
3.4 Global Manufacturers Antipyretic Analgesics Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Antipyretic Analgesics Product Location Distribution
3.4.2 Players Antipyretic Analgesics Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Antipyretic Analgesics by Region
4.1 Global Antipyretic Analgesics by Region
4.1.1 Global Antipyretic Analgesics Sales by Region
4.1.2 Global Antipyretic Analgesics Revenue by Region
4.2 Americas Antipyretic Analgesics Sales Growth
4.3 APAC Antipyretic Analgesics Sales Growth
4.4 Europe Antipyretic Analgesics Sales Growth
4.5 Middle East & Africa Antipyretic Analgesics Sales Growth

5 Americas
5.1 Americas Antipyretic Analgesics Sales by Country
5.1.1 Americas Antipyretic Analgesics Sales by Country (2016-2021)
5.1.2 Americas Antipyretic Analgesics Revenue by Country (2016-2021)
5.2 Americas Antipyretic Analgesics Sales by Type
5.3 Americas Antipyretic Analgesics Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC
6.1 APAC Antipyretic Analgesics Sales by Region
6.1.1 APAC Antipyretic Analgesics Sales by Region (2016-2021)
6.1.2 APAC Antipyretic Analgesics Revenue by Region (2016-2021)
6.2 APAC Antipyretic Analgesics Sales by Type
6.3 APAC Antipyretic Analgesics Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 Europe
7.1 Europe Antipyretic Analgesics by Country
7.1.1 Europe Antipyretic Analgesics Sales by Country (2016-2021)
7.1.2 Europe Antipyretic Analgesics Revenue by Country (2016-2021)
7.2 Europe Antipyretic Analgesics Sales by Type
7.3 Europe Antipyretic Analgesics Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 Middle East & Africa
8.1 Middle East & Africa Antipyretic Analgesics by Country
8.1.1 Middle East & Africa Antipyretic Analgesics Sales by Country (2016-2021)
8.1.2 Middle East & Africa Antipyretic Analgesics Revenue by Country (2016-2021)
8.2 Middle East & Africa Antipyretic Analgesics Sales by Type
8.3 Middle East & Africa Antipyretic Analgesics Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Antipyretic Analgesics Distributors
10.3 Antipyretic Analgesics Customer

11 Global Antipyretic Analgesics Market Forecast
11.1 Global Antipyretic Analgesics Forecast by Region
11.1.1 Global Antipyretic Analgesics Forecast by Regions (2021-2026)
11.2.2 Global Antipyretic Analgesics Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Country
11.3 APAC Forecast by Region
11.4 Europe Forecast by Country
11.5 Middle East & Africa Forecast by Country
11.6 Global Antipyretic Analgesics Forecast by Type
11.7 Global Antipyretic Analgesics Forecast by Application

12 Key Players Analysis
12.1 Mallinckrodt Pharmaceuticals
12.1.1 Mallinckrodt Pharmaceuticals Company Information
12.1.2 Mallinckrodt Pharmaceuticals Antipyretic Analgesics Product Offered
12.1.3 Mallinckrodt Pharmaceuticals Antipyretic Analgesics Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 Mallinckrodt Pharmaceuticals Main Business Overview
12.1.5 Mallinckrodt Pharmaceuticals Latest Developments
12.2 IOL
12.2.1 IOL Company Information
12.2.2 IOL Antipyretic Analgesics Product Offered
12.2.3 IOL Antipyretic Analgesics Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 IOL Main Business Overview
12.2.5 IOL Latest Developments
12.3 Anqiu Lu’an Pharmaceutical
12.3.1 Anqiu Lu’an Pharmaceutical Company Information
12.3.2 Anqiu Lu’an Pharmaceutical Antipyretic Analgesics Product Offered
12.3.3 Anqiu Lu’an Pharmaceutical Antipyretic Analgesics Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 Anqiu Lu’an Pharmaceutical Main Business Overview
12.3.5 Anqiu Lu’an Pharmaceutical Latest Developments
12.4 Novacyl
12.4.1 Novacyl Company Information
12.4.2 Novacyl Antipyretic Analgesics Product Offered
12.4.3 Novacyl Antipyretic Analgesics Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 Novacyl Main Business Overview
12.4.5 Novacyl Latest Developments
12.5 BASF
12.5.1 BASF Company Information
12.5.2 BASF Antipyretic Analgesics Product Offered
12.5.3 BASF Antipyretic Analgesics Sales, Revenue, Price and Gross Margin (2019-2021)
12.5.4 BASF Main Business Overview
12.5.5 BASF Latest Developments
12.6 Anhui BBCA Pharmaceuticals
12.6.1 Anhui BBCA Pharmaceuticals Company Information
12.6.2 Anhui BBCA Pharmaceuticals Antipyretic Analgesics Product Offered
12.6.3 Anhui BBCA Pharmaceuticals Antipyretic Analgesics Sales, Revenue, Price and Gross Margin (2019-2021)
12.6.4 Anhui BBCA Pharmaceuticals Main Business Overview
12.6.5 Anhui BBCA Pharmaceuticals Latest Developments
12.7 Hubei Biocause
12.7.1 Hubei Biocause Company Information
12.7.2 Hubei Biocause Antipyretic Analgesics Product Offered
12.7.3 Hubei Biocause Antipyretic Analgesics Sales, Revenue, Price and Gross Margin (2019-2021)
12.7.4 Hubei Biocause Main Business Overview
12.7.5 Hubei Biocause Latest Developments
12.8 Xinhua Pharm
12.8.1 Xinhua Pharm Company Information
12.8.2 Xinhua Pharm Antipyretic Analgesics Product Offered
12.8.3 Xinhua Pharm Antipyretic Analgesics Sales, Revenue, Price and Gross Margin (2019-2021)
12.8.4 Xinhua Pharm Main Business Overview
12.8.5 Xinhua Pharm Latest Developments
12.9 Granules India Limited
12.9.1 Granules India Limited Company Information
12.9.2 Granules India Limited Antipyretic Analgesics Product Offered
12.9.3 Granules India Limited Antipyretic Analgesics Sales, Revenue, Price and Gross Margin (2019-2021)
12.9.4 Granules India Limited Main Business Overview
12.9.5 Granules India Limited Latest Developments
12.10 Huagang Pharm
12.10.1 Huagang Pharm Company Information
12.10.2 Huagang Pharm Antipyretic Analgesics Product Offered
12.10.3 Huagang Pharm Antipyretic Analgesics Sales, Revenue, Price and Gross Margin (2019-2021)
12.10.4 Huagang Pharm Main Business Overview
12.10.5 Huagang Pharm Latest Developments
12.11 Hebei Jiheng Pharmaceutical
12.11.1 Hebei Jiheng Pharmaceutical Company Information
12.11.2 Hebei Jiheng Pharmaceutical Antipyretic Analgesics Product Offered
12.11.3 Hebei Jiheng Pharmaceutical Antipyretic Analgesics Sales, Revenue, Price and Gross Margin (2019-2021)
12.11.4 Hebei Jiheng Pharmaceutical Main Business Overview
12.11.5 Hebei Jiheng Pharmaceutical Latest Developments
12.12 Zhejiang Kangle Pharmaceutical
12.12.1 Zhejiang Kangle Pharmaceutical Company Information
12.12.2 Zhejiang Kangle Pharmaceutical Antipyretic Analgesics Product Offered
12.12.3 Zhejiang Kangle Pharmaceutical Antipyretic Analgesics Sales, Revenue, Price and Gross Margin (2019-2021)
12.12.4 Zhejiang Kangle Pharmaceutical Main Business Overview
12.12.5 Zhejiang Kangle Pharmaceutical Latest Developments
12.13 Hebei Jingye Medical Technology
12.13.1 Hebei Jingye Medical Technology Company Information
12.13.2 Hebei Jingye Medical Technology Antipyretic Analgesics Product Offered
12.13.3 Hebei Jingye Medical Technology Antipyretic Analgesics Sales, Revenue, Price and Gross Margin (2019-2021)
12.13.4 Hebei Jingye Medical Technology Main Business Overview
12.13.5 Hebei Jingye Medical Technology Latest Developments
12.14 MSPF
12.14.1 MSPF Company Information
12.14.2 MSPF Antipyretic Analgesics Product Offered
12.14.3 MSPF Antipyretic Analgesics Sales, Revenue, Price and Gross Margin (2019-2021)
12.14.4 MSPF Main Business Overview
12.14.5 MSPF Latest Developments

13 Research Findings and Conclusion

List of Tables
Table 1. Antipyretic Analgesics Consumption CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Paracetamol
Table 3. Major Players of Aspirin
Table 4. Major Players of Ibuprofen
Table 5. Major Players of Naproxen
Table 6. Major Players of Diclofenac
Table 7. Major Players of Oxaprozin
Table 8. Major Players of Dexibuprofen
Table 9. Major Players of Others
Table 10. Global Antipyretic Analgesics Sales by Type (2016-2021) & (MT)
Table 11. Global Antipyretic Analgesics Sales Market Share by Type (2016-2021)
Table 12. Global Antipyretic Analgesics Revenue by Type (2016-2021) & ($ million)
Table 13. Global Antipyretic Analgesics Revenue Market Share by Type (2016-2021)
Table 14. Global Antipyretic Analgesics Sale Price by Type (2016-2021)
Table 15. Global Antipyretic Analgesics Sales by Application (2016-2021) & (MT)
Table 16. Global Antipyretic Analgesics Sales Market Share by Application (2016-2021)
Table 17. Global Antipyretic Analgesics Value by Application (2016-2021)
Table 18. Global Antipyretic Analgesics Revenue Market Share by Application (2016-2021)
Table 19. Global Antipyretic Analgesics Sale Price by Application (2016-2021)
Table 20. Global Antipyretic Analgesics Sales by Company (2019-2021) & (MT)
Table 21. Global Antipyretic Analgesics Sales Market Share by Company (2019-2021)
Table 22. Global Antipyretic Analgesics Revenue by Company (2019-2021) ($ Millions)
Table 23. Global Antipyretic Analgesics Revenue Market Share by Company (2019-2021)
Table 24. Global Antipyretic Analgesics Sale Price by Company (2019-2021)
Table 25. Key Manufacturers Antipyretic Analgesics Producing Area Distribution and Sales Area
Table 26. Players Antipyretic Analgesics Products Offered
Table 27. Antipyretic Analgesics Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
Table 28. New Products and Potential Entrants
Table 29. Mergers & Acquisitions, Expansion
Table 30. Global Antipyretic Analgesics Sales by Region (2016-2021) (MT)
Table 31. Global Antipyretic Analgesics Sales Market Share by Region (2016-2021)
Table 32. Global Antipyretic Analgesics Revenue by Region (2016-2021) & ($ Millions)
Table 33. Global Antipyretic Analgesics Revenue Market Share by Region (2016-2021)
Table 34. Americas Antipyretic Analgesics Sales by Country (2016-2021) & (MT)
Table 35. Americas Antipyretic Analgesics Sales Market Share by Country (2016-2021)
Table 36. Americas Antipyretic Analgesics Revenue by Country (2016-2021) & ($ Millions)
Table 37. Americas Antipyretic Analgesics Revenue Market Share by Country (2016-2021)
Table 38. Americas Antipyretic Analgesics Sales by Type (2016-2021) & (MT)
Table 39. Americas Antipyretic Analgesics Sales Market Share by Type (2016-2021)
Table 40. Americas Antipyretic Analgesics Sales by Application (2016-2021) & (MT)
Table 41. Americas Antipyretic Analgesics Sales Market Share by Application (2016-2021)
Table 42. APAC Antipyretic Analgesics Sales by Region (2016-2021) & (MT)
Table 43. APAC Antipyretic Analgesics Sales Market Share by Region (2016-2021)
Table 44. APAC Antipyretic Analgesics Revenue by Region (2016-2021) & ($ Millions)
Table 45. APAC Antipyretic Analgesics Revenue Market Share by Region (2016-2021)
Table 46. APAC Antipyretic Analgesics Sales by Type (2016-2021) & (MT)
Table 47. APAC Antipyretic Analgesics Sales Market Share by Type (2016-2021)
Table 48. APAC Antipyretic Analgesics Sales by Application (2016-2021) & (MT)
Table 49. APAC Antipyretic Analgesics Sales Market Share by Application (2016-2021)
Table 50. Europe Antipyretic Analgesics Sales by Country (2016-2021) & (MT)
Table 51. Europe Antipyretic Analgesics Sales Market Share by Country (2016-2021)
Table 52. Europe Antipyretic Analgesics Revenue by Country (2016-2021) & ($ Millions)
Table 53. Europe Antipyretic Analgesics Revenue Market Share by Country (2016-2021)
Table 54. Europe Antipyretic Analgesics Sales by Type (2016-2021) & (MT)
Table 55. Europe Antipyretic Analgesics Sales Market Share by Type (2016-2021)
Table 56. Europe Antipyretic Analgesics Sales by Application (2016-2021) & (MT)
Table 57. Europe Antipyretic Analgesics Sales Market Share by Application (2016-2021)
Table 58. Middle East & Africa Antipyretic Analgesics Sales by Country (2016-2021) & (MT)
Table 59. Middle East & Africa Antipyretic Analgesics Sales Market Share by Country (2016-2021)
Table 60. Middle East & Africa Antipyretic Analgesics Revenue by Country (2016-2021) & ($ Millions)
Table 61. Middle East & Africa Antipyretic Analgesics Revenue Market Share by Country (2016-2021)
Table 62. Middle East & Africa Antipyretic Analgesics Sales by Type (2016-2021) & (MT)
Table 63. Middle East & Africa Antipyretic Analgesics Sales Market Share by Type (2016-2021)
Table 64. Middle East & Africa Antipyretic Analgesics Sales by Application (2016-2021) & (MT)
Table 65. Middle East & Africa Antipyretic Analgesics Sales Market Share by Application (2016-2021)
Table 66. Key and Potential Regions of Antipyretic Analgesics
Table 67. Key Application and Potential Industries of Antipyretic Analgesics
Table 68. Key Challenges of Antipyretic Analgesics
Table 69. Key Trends of Antipyretic Analgesics
Table 70. Antipyretic Analgesics Distributors List
Table 71. Antipyretic Analgesics Customer List
Table 72. Global Antipyretic Analgesics Sales Forecast by Region (2021-2026) & (MT)
Table 73. Global Antipyretic Analgesics Consumption Market Forecast by Region
Table 74. Global Antipyretic Analgesics Revenue Forecast by Region (2021-2026) & ($ millions)
Table 75. Global Antipyretic Analgesics Revenue Market Share Forecast by Region (2021-2026)
Table 76. Americas Antipyretic Analgesics Sales Forecast by Country (2021-2026) & (MT)
Table 77. Americas Antipyretic Analgesics Revenue Forecast by Country (2021-2026) & ($ millions)
Table 78. APAC Antipyretic Analgesics Sales Forecast by Region (2021-2026) & (MT)
Table 79. APAC Antipyretic Analgesics Revenue Forecast by Region (2021-2026) & ($ millions)
Table 80. Europe Antipyretic Analgesics Sales Forecast by Country (2021-2026) & (MT)
Table 81. Europe Antipyretic Analgesics Revenue Forecast by Country (2021-2026) & ($ millions)
Table 82. Middle East & Africa Antipyretic Analgesics Sales Forecast by Country (2021-2026) & (MT)
Table 83. Middle East & Africa Antipyretic Analgesics Revenue Forecast by Country (2021-2026) & ($ millions)
Table 84. Global Antipyretic Analgesics Sales Forecast by Type (2021-2026) & (MT)
Table 85. Global Antipyretic Analgesics Sales Market Share Forecast by Type (2021-2026)
Table 86. Global Antipyretic Analgesics Revenue Forecast by Type (2021-2026) & ($ Millions)
Table 87. Global Antipyretic Analgesics Revenue Market Share Forecast by Type (2021-2026)
Table 88. Global Antipyretic Analgesics Sales Forecast by Application (2021-2026) & (MT)
Table 89. Global Antipyretic Analgesics Sales Market Share Forecast by Application (2021-2026)
Table 90. Global Antipyretic Analgesics Revenue Forecast by Application (2021-2026) & ($ Millions)
Table 91. Global Antipyretic Analgesics Revenue Market Share Forecast by Application (2021-2026)
Table 92. Mallinckrodt Pharmaceuticals Basic Information, Antipyretic Analgesics Manufacturing Base, Sales Area and Its Competitors
Table 93. Mallinckrodt Pharmaceuticals Antipyretic Analgesics Product Offered
Table 94. Mallinckrodt Pharmaceuticals Antipyretic Analgesics Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E)
Table 95. Mallinckrodt Pharmaceuticals Main Business
Table 96. Mallinckrodt Pharmaceuticals Latest Developments
Table 97. IOL Basic Information, Antipyretic Analgesics Manufacturing Base, Sales Area and Its Competitors
Table 98. IOL Antipyretic Analgesics Product Offered
Table 99. IOL Antipyretic Analgesics Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E)
Table 100. IOL Main Business
Table 101. IOL Latest Developments
Table 102. Anqiu Lu'an Pharmaceutical Basic Information, Antipyretic Analgesics Manufacturing Base, Sales Area and Its Competitors
Table 103. Anqiu Lu'an Pharmaceutical Antipyretic Analgesics Product Offered
Table 104. Anqiu Lu'an Pharmaceutical Antipyretic Analgesics Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E)
Table 105. Anqiu Lu'an Pharmaceutical Main Business
Table 106. Anqiu Lu'an Pharmaceutical Latest Developments
Table 107. Novacyl Basic Information, Antipyretic Analgesics Manufacturing Base, Sales Area and Its Competitors
Table 108. Novacyl Antipyretic Analgesics Product Offered
Table 109. Novacyl Antipyretic Analgesics Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E)
Table 110. Novacyl Main Business
Table 111. Novacyl Latest Developments
Table 112. BASF Basic Information, Antipyretic Analgesics Manufacturing Base, Sales Area and Its Competitors
Table 113. BASF Antipyretic Analgesics Product Offered
Table 114. BASF Antipyretic Analgesics Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E)
Table 115. BASF Main Business
Table 116. BASF Latest Developments
Table 117. Anhui BBCA Pharmaceuticals Basic Information, Antipyretic Analgesics Manufacturing Base, Sales Area and Its Competitors
Table 118. Anhui BBCA Pharmaceuticals Antipyretic Analgesics Product Offered
Table 119. Anhui BBCA Pharmaceuticals Antipyretic Analgesics Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E)
Table 120. Anhui BBCA Pharmaceuticals Main Business
Table 121. Anhui BBCA Pharmaceuticals Latest Developments
Table 122. Hubei Biocause Basic Information, Antipyretic Analgesics Manufacturing Base, Sales Area and Its Competitors
Table 123. Hubei Biocause Antipyretic Analgesics Product Offered
Table 124. Hubei Biocause Antipyretic Analgesics Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E)
Table 125. Hubei Biocause Main Business
Table 126. Hubei Biocause Latest Developments
Table 127. Xinhua Pharm Basic Information, Antipyretic Analgesics Manufacturing Base, Sales Area and Its Competitors
Table 128. Xinhua Pharm Antipyretic Analgesics Product Offered
Table 129. Xinhua Pharm Antipyretic Analgesics Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E)
Table 130. Xinhua Pharm Main Business
Table 131. Xinhua Pharm Latest Developments
Table 132. Granules India Limited Basic Information, Antipyretic Analgesics Manufacturing Base, Sales Area and Its Competitors
Table 133. Granules India Limited Antipyretic Analgesics Product Offered
Table 134. Granules India Limited Antipyretic Analgesics Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E)
Table 135. Granules India Limited Main Business
Table 136. Granules India Limited Latest Developments
Table 137. Huagang Pharm Basic Information, Antipyretic Analgesics Manufacturing Base, Sales Area and Its Competitors
Table 138. Huagang Pharm Antipyretic Analgesics Product Offered
Table 139. Huagang Pharm Antipyretic Analgesics Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E)
Table 140. Huagang Pharm Main Business
Table 141. Huagang Pharm Latest Developments
Table 142. Hebei Jiheng Pharmaceutical Basic Information, Antipyretic Analgesics Manufacturing Base, Sales Area and Its Competitors
Table 143. Hebei Jiheng Pharmaceutical Antipyretic Analgesics Product Offered
Table 144. Hebei Jiheng Pharmaceutical Antipyretic Analgesics Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E)
Table 145. Hebei Jiheng Pharmaceutical Main Business
Table 146. Hebei Jiheng Pharmaceutical Latest Developments
Table 147. Zhejiang Kangle Pharmaceutical Basic Information, Antipyretic Analgesics Manufacturing Base, Sales Area and Its Competitors
Table 148. Zhejiang Kangle Pharmaceutical Antipyretic Analgesics Product Offered
Table 149. Zhejiang Kangle Pharmaceutical Antipyretic Analgesics Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E)
Table 150. Zhejiang Kangle Pharmaceutical Main Business
Table 151. Zhejiang Kangle Pharmaceutical Latest Developments
Table 152. Hebei Jingye Medical Technology Basic Information, Antipyretic Analgesics Manufacturing Base, Sales Area and Its Competitors
Table 153. Hebei Jingye Medical Technology Antipyretic Analgesics Product Offered
Table 154. Hebei Jingye Medical Technology Antipyretic Analgesics Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E)
Table 155. Hebei Jingye Medical Technology Main Business
Table 156. Hebei Jingye Medical Technology Latest Developments
Table 157. MSPF Basic Information, Antipyretic Analgesics Manufacturing Base, Sales Area and Its Competitors
Table 158. MSPF Antipyretic Analgesics Product Offered
Table 159. MSPF Antipyretic Analgesics Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E)
Table 160. MSPF Main Business
Table 161. MSPF Latest Developments
List of Figures
Figure 1. Picture of Antipyretic Analgesics
Figure 2. Antipyretic Analgesics Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Antipyretic Analgesics Sales Growth Rate 2016-2026 (MT)
Figure 7. Global Antipyretic Analgesics Revenue Growth Rate 2016-2026 ($ Millions)
Figure 8. Antipyretic Analgesics Sales by Region (2021 & 2026) & ($ millions)
Figure 9. Product Picture of Paracetamol
Figure 10. Product Picture of Aspirin
Figure 11. Product Picture of Ibuprofen
Figure 12. Product Picture of Naproxen
Figure 13. Product Picture of Diclofenac
Figure 14. Product Picture of Oxaprozin
Figure 15. Product Picture of Dexibuprofen
Figure 16. Product Picture of Others
Figure 17. Global Antipyretic Analgesics Sales Market Share by Type in 2020
Figure 18. Global Antipyretic Analgesics Revenue Market Share by Type (2016-2021)
Figure 19. Antipyretic Analgesics Consumed in Adults
Figure 20. Global Antipyretic Analgesics Market: Adults (2016-2021) & (MT)
Figure 21. Antipyretic Analgesics Consumed in Children
Figure 22. Global Antipyretic Analgesics Market: Children (2016-2021) & (MT)
Figure 23. Global Antipyretic Analgesics Sales Market Share by Application (2016-2021)
Figure 24. Global Antipyretic Analgesics Revenue Market Share by Application in 2020
Figure 25. Antipyretic Analgesics Revenue Market by Company in 2020 ($ Million)
Figure 26. Global Antipyretic Analgesics Revenue Market Share by Company in 2020
Figure 27. Global Antipyretic Analgesics Sales Market Share by Regions (2016-2021)
Figure 28. Global Antipyretic Analgesics Revenue Market Share by Region in 2020
Figure 29. Americas Antipyretic Analgesics Sales 2016-2021 (MT)
Figure 30. Americas Antipyretic Analgesics Revenue 2016-2021 ($ Millions)
Figure 31. APAC Antipyretic Analgesics Sales 2016-2021 (MT)
Figure 32. APAC Antipyretic Analgesics Revenue 2016-2021 ($ Millions)
Figure 33. Europe Antipyretic Analgesics Sales 2016-2021 (MT)
Figure 34. Europe Antipyretic Analgesics Revenue 2016-2021 ($ Millions)
Figure 35. Middle East & Africa Antipyretic Analgesics Sales 2016-2021 (MT)
Figure 36. Middle East & Africa Antipyretic Analgesics Revenue 2016-2021 ($ Millions)
Figure 37. Americas Antipyretic Analgesics Sales Market Share by Country in 2020
Figure 38. Americas Antipyretic Analgesics Revenue Market Share by Country in 2020
Figure 39. Americas Antipyretic Analgesics Sales Market Share by Type in 2020
Figure 40. Americas Antipyretic Analgesics Sales Market Share by Application in 2020
Figure 41. United States Antipyretic Analgesics Revenue Growth 2016-2021 ($ Millions)
Figure 42. Canada Antipyretic Analgesics Revenue Growth 2016-2021 ($ Millions)
Figure 43. Mexico Antipyretic Analgesics Revenue Growth 2016-2021 ($ Millions)
Figure 44. Brazil Antipyretic Analgesics Revenue Growth 2016-2021 ($ Millions)
Figure 45. APAC Antipyretic Analgesics Sales Market Share by Region in 2020
Figure 46. APAC Antipyretic Analgesics Revenue Market Share by Regions in 2020
Figure 47. APAC Antipyretic Analgesics Sales Market Share by Type in 2020
Figure 48. APAC Antipyretic Analgesics Sales Market Share by Application in 2020
Figure 49. China Antipyretic Analgesics Revenue Growth 2016-2021 ($ Millions)
Figure 50. Japan Antipyretic Analgesics Revenue Growth 2016-2021 ($ Millions)
Figure 51. Korea Antipyretic Analgesics Revenue Growth 2016-2021 ($ Millions)
Figure 52. Southeast Asia Antipyretic Analgesics Revenue Growth 2016-2021 ($ Millions)
Figure 53. India Antipyretic Analgesics Revenue Growth 2016-2021 ($ Millions)
Figure 54. Australia Antipyretic Analgesics Revenue Growth 2016-2021 ($ Millions)
Figure 55. Europe Antipyretic Analgesics Sales Market Share by Country in 2020
Figure 56. Europe Antipyretic Analgesics Revenue Market Share by Country in 2020
Figure 57. Europe Antipyretic Analgesics Sales Market Share by Type in 2020
Figure 58. Europe Antipyretic Analgesics Sales Market Share by Application in 2020
Figure 59. Germany Antipyretic Analgesics Revenue Growth 2016-2021 ($ Millions)
Figure 60. France Antipyretic Analgesics Revenue Growth 2016-2021 ($ Millions)
Figure 61. UK Antipyretic Analgesics Revenue Growth 2016-2021 ($ Millions)
Figure 62. Italy Antipyretic Analgesics Revenue Growth 2016-2021 ($ Millions)
Figure 63. Russia Antipyretic Analgesics Revenue Growth 2016-2021 ($ Millions)
Figure 64. Middle East & Africa Antipyretic Analgesics Sales Market Share by Country in 2020
Figure 65. Middle East & Africa Antipyretic Analgesics Revenue Market Share by Country in 2020
Figure 66. Middle East & Africa Antipyretic Analgesics Sales Market Share by Type in 2020
Figure 67. Middle East & Africa Antipyretic Analgesics Sales Market Share by Application in 2020
Figure 68. Egypt Antipyretic Analgesics Revenue Growth 2016-2021 ($ Millions)
Figure 69. South Africa Antipyretic Analgesics Revenue Growth 2016-2021 ($ Millions)
Figure 70. Israel Antipyretic Analgesics Revenue Growth 2016-2021 ($ Millions)
Figure 71. Turkey Antipyretic Analgesics Revenue Growth 2016-2021 ($ Millions)
Figure 72. GCC Country Antipyretic Analgesics Revenue Growth 2016-2021 ($ Millions)
Figure 73. Channels of Distribution
Figure 74. Distributors Profiles


★調査レポート[世界の解熱鎮痛薬市場予測 2021年-2026年] (コード：LPI21MY9423)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の解熱鎮痛薬市場予測 2021年-2026年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の解熱鎮痛薬用有効成分市場予測 2021年-2026年
    LPI21MY0712 / LP Information / 2021年5月 / LPインフォメーション社の「解熱鎮痛薬用有効成分の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、パラセタモール、アスピリン、イブプロフェン、ナプロキセン、ジクロフェナク、オキサプロジン、デキシブプロフェン、その他など、用途別には、頭痛・発熱、風邪・咳、筋肉痙攣、その他などにセグメント区分してまとめました。解熱鎮痛薬用有効成分のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・解熱鎮痛薬用有効成分の世界市場概要（サマリー） ・解熱鎮痛薬用有効成分の企業別販売量・売上 ・解熱鎮痛薬用有効成分の企業別市場シェア ・解熱鎮痛薬用有効成分の世界市場規模 2016年-2021年：種類別（パラセタモール、アスピリン、イブプロフェン、ナプロキセン、ジクロフェナク、オキサプロジン、デキシブプロフェン、その他） ・解熱鎮痛薬用有効成分の世界市場規模 2016年-2021年：用途別（頭痛・発熱、風邪・咳、筋肉痙攣、その他） ・解熱鎮痛薬用有効成分の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・解熱鎮痛薬用有効成分のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2021 growth of Antipyretic Analgesic Active Pharmaceutical Ingredients will have significant change from previous year. By the most conservative estimates of global Antipyretic Analgesic Active Pharmaceutical Ingredients market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Antipyretic Analgesic Active Pharmaceutical Ingredients market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026. This report presents a comprehensive overview, market shares, and growth opportunities of Antipyretic...
  • 世界の鎮痛剤輸液ポンプ市場予測 2021年-2026年
    LPI21MY8708 / LP Information / 2021年5月 / LPインフォメーション社の「鎮痛剤輸液ポンプの世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、容積式鎮痛輸液ポンプ、携帯型鎮痛輸液ポンプ、注射器鎮痛輸液ポンプなど、用途別には、術後用、事故・外傷、陣痛、癌患者、その他などにセグメント区分してまとめました。鎮痛剤輸液ポンプのグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・鎮痛剤輸液ポンプの世界市場概要（サマリー） ・鎮痛剤輸液ポンプの企業別販売量・売上 ・鎮痛剤輸液ポンプの企業別市場シェア ・鎮痛剤輸液ポンプの世界市場規模 2016年-2021年：種類別（容積式鎮痛輸液ポンプ、携帯型鎮痛輸液ポンプ、注射器鎮痛輸液ポンプ） ・鎮痛剤輸液ポンプの世界市場規模 2016年-2021年：用途別（術後用、事故・外傷、陣痛、癌患者、その他） ・鎮痛剤輸液ポンプの南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・鎮痛剤輸液ポンプのアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Analgesics Infusion Pump will have significant change from previous year. By the most conservative estimates of global Analgesics Infusion Pump market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Analgesics Infusion Pump market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Analgesics Infusion Pump market by product type,...
  • 世界のアセチルサリチル酸市場予測 2021年-2026年
    LPI21MY0534 / LP Information / 2021年5月 / LPインフォメーション社の「アセチルサリチル酸の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、アセチルサリチル酸テーブル、アセチルサリチル酸カプセル、その他など、用途別には、解熱鎮痛薬、関節リウマチ、その他などにセグメント区分してまとめました。アセチルサリチル酸のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・アセチルサリチル酸の世界市場概要（サマリー） ・アセチルサリチル酸の企業別販売量・売上 ・アセチルサリチル酸の企業別市場シェア ・アセチルサリチル酸の世界市場規模 2016年-2021年：種類別（アセチルサリチル酸テーブル、アセチルサリチル酸カプセル、その他） ・アセチルサリチル酸の世界市場規模 2016年-2021年：用途別（解熱鎮痛薬、関節リウマチ、その他） ・アセチルサリチル酸の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・アセチルサリチル酸のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Acetylsalicylic Acid will have significant change from previous year. By the most conservative estimates of global Acetylsalicylic Acid market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Acetylsalicylic Acid market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Acetylsalicylic Acid market by product type, application, key manufacturers and...
  • 世界の製薬アイソレーター市場予測 2021年-2026年
    LPI21MY9192 / LP Information / 2021年5月 / LPインフォメーション社の「製薬アイソレーターの世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、無菌試験アイソレーター、無菌生産アイソレーターなど、用途別には、病院＆診断ラボ、製薬＆バイオテクノロジー産業、研究＆学術などにセグメント区分してまとめました。製薬アイソレーターのグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・製薬アイソレーターの世界市場概要（サマリー） ・製薬アイソレーターの企業別販売量・売上 ・製薬アイソレーターの企業別市場シェア ・製薬アイソレーターの世界市場規模 2016年-2021年：種類別（無菌試験アイソレーター、無菌生産アイソレーター） ・製薬アイソレーターの世界市場規模 2016年-2021年：用途別（病院＆診断ラボ、製薬＆バイオテクノロジー産業、研究＆学術） ・製薬アイソレーターの南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・製薬アイソレーターのアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Pharmaceutical Isolator will have significant change from previous year. By the most conservative estimates of global Pharmaceutical Isolator market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ 387 million in 2019. Over the next five years the Pharmaceutical Isolator market will register a 2.1% CAGR in terms of revenue, the global market size will reach US$ 420.4 million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Pharmaceutical Isolator market by product type, application, key manufacturers and...
  • 世界の医薬品容器市場予測 2021年-2026年
    LPI21MY9190 / LP Information / 2021年5月 / LPインフォメーション社の「医薬品容器の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、ガラス容器、プラスチック容器、金属容器など、用途別には、食品、医療、化学、その他などにセグメント区分してまとめました。医薬品容器のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・医薬品容器の世界市場概要（サマリー） ・医薬品容器の企業別販売量・売上 ・医薬品容器の企業別市場シェア ・医薬品容器の世界市場規模 2016年-2021年：種類別（ガラス容器、プラスチック容器、金属容器） ・医薬品容器の世界市場規模 2016年-2021年：用途別（食品、医療、化学、その他） ・医薬品容器の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・医薬品容器のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Pharmaceutical Containers will have significant change from previous year. By the most conservative estimates of global Pharmaceutical Containers market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Pharmaceutical Containers market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Pharmaceutical Containers market by product type, application, key manufacturers and...
  • 世界の製薬ろ過装置市場予測 2021年-2026年
    LPI21MY9191 / LP Information / 2021年5月 / LPインフォメーション社の「製薬ろ過装置の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、精密ろ過装置、限外濾過装置、ナノ濾過装置、その他など、用途別には、研究所、契約製造組織、製薬会社などにセグメント区分してまとめました。製薬ろ過装置のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・製薬ろ過装置の世界市場概要（サマリー） ・製薬ろ過装置の企業別販売量・売上 ・製薬ろ過装置の企業別市場シェア ・製薬ろ過装置の世界市場規模 2016年-2021年：種類別（精密ろ過装置、限外濾過装置、ナノ濾過装置、その他） ・製薬ろ過装置の世界市場規模 2016年-2021年：用途別（研究所、契約製造組織、製薬会社） ・製薬ろ過装置の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・製薬ろ過装置のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Pharmaceutical Filtration Equipment will have significant change from previous year. By the most conservative estimates of global Pharmaceutical Filtration Equipment market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Pharmaceutical Filtration Equipment market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Pharmaceutical Filtration Equipment market by product type,...
  • 世界の動物用医薬品市場予測 2021年-2026年
    LPI21MY9405 / LP Information / 2021年5月 / LPインフォメーション社の「動物用医薬品の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、ワクチン、動物用医薬品、その他など、用途別には、コンパニオンアニマル、家禽、その他などにセグメント区分してまとめました。動物用医薬品のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・動物用医薬品の世界市場概要（サマリー） ・動物用医薬品の企業別販売量・売上 ・動物用医薬品の企業別市場シェア ・動物用医薬品の世界市場規模 2016年-2021年：種類別（ワクチン、動物用医薬品、その他） ・動物用医薬品の世界市場規模 2016年-2021年：用途別（コンパニオンアニマル、家禽、その他） ・動物用医薬品の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・動物用医薬品のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Animal Pharmaceutical will have significant change from previous year. By the most conservative estimates of global Animal Pharmaceutical market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Animal Pharmaceutical market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Animal Pharmaceutical market by product type, application, key manufacturers and...
  • 世界の滅菌有効成分市場予測 2021年-2026年
    LPI21MY9657 / LP Information / 2021年5月 / LPインフォメーション社の「滅菌有効成分の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、水性、非水性液体、乾燥粉末、その他など、用途別には、CNS、心臓血管、泌尿生殖器/ホルモン剤、呼吸器、リウマチ、糖尿病、腫瘍学、その他などにセグメント区分してまとめました。滅菌有効成分のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・滅菌有効成分の世界市場概要（サマリー） ・滅菌有効成分の企業別販売量・売上 ・滅菌有効成分の企業別市場シェア ・滅菌有効成分の世界市場規模 2016年-2021年：種類別（水性、非水性液体、乾燥粉末、その他） ・滅菌有効成分の世界市場規模 2016年-2021年：用途別（CNS、心臓血管、泌尿生殖器/ホルモン剤、呼吸器、リウマチ、糖尿病、腫瘍学、その他） ・滅菌有効成分の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・滅菌有効成分のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Sterile Active Pharmaceutical Ingredients will have significant change from previous year. By the most conservative estimates of global Sterile Active Pharmaceutical Ingredients market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Sterile Active Pharmaceutical Ingredients market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Sterile Active Pharmaceutical Ingredients...
  • 世界の抗生物質API市場予測 2021年-2026年
    LPI21MY9413 / LP Information / 2021年5月 / LPインフォメーション社の「抗生物質APIの世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、ペニシリン、セファロスポリン、アミノグリコシド、テトラサイクリン、キノロン、マクロライド、リンコマイシン、その他など、用途別には、経口薬、注射薬などにセグメント区分してまとめました。抗生物質APIのグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・抗生物質APIの世界市場概要（サマリー） ・抗生物質APIの企業別販売量・売上 ・抗生物質APIの企業別市場シェア ・抗生物質APIの世界市場規模 2016年-2021年：種類別（ペニシリン、セファロスポリン、アミノグリコシド、テトラサイクリン、キノロン、マクロライド、リンコマイシン、その他） ・抗生物質APIの世界市場規模 2016年-2021年：用途別（経口薬、注射薬） ・抗生物質APIの南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・抗生物質APIのアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Antibiotic API will have significant change from previous year. By the most conservative estimates of global Antibiotic API market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ 5885.2 million in 2019. Over the next five years the Antibiotic API market will register a -0.9% CAGR in terms of revenue, the global market size will reach US$ 5675.6 million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Antibiotic API market by product type, application, key manufacturers and...
  • 世界の高性能医薬品有効成分（HPAPI）市場予測 2021年-2026年
    LPI21MY9636 / LP Information / 2021年5月 / LPインフォメーション社の「高性能医薬品有効成分（HPAPI）の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、合成成分、生物学的成分など、用途別には、腫瘍、緑内障、抗糖尿病、心臓血管、筋骨格、ホルモン、その他などにセグメント区分してまとめました。高性能医薬品有効成分（HPAPI）のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・高性能医薬品有効成分（HPAPI）の世界市場概要（サマリー） ・高性能医薬品有効成分（HPAPI）の企業別販売量・売上 ・高性能医薬品有効成分（HPAPI）の企業別市場シェア ・高性能医薬品有効成分（HPAPI）の世界市場規模 2016年-2021年：種類別（合成成分、生物学的成分） ・高性能医薬品有効成分（HPAPI）の世界市場規模 2016年-2021年：用途別（腫瘍、緑内障、抗糖尿病、心臓血管、筋骨格、ホルモン、その他） ・高性能医薬品有効成分（HPAPI）の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・高性能医薬品有効成分（HPAPI）のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of High Performance Active Pharmaceutical Ingredients (HPAPI) will have significant change from previous year. By the most conservative estimates of global High Performance Active Pharmaceutical Ingredients (HPAPI) market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the High Performance Active Pharmaceutical Ingredients (HPAPI) market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025. This report presents a comprehensive overview, market shares, and growth...

    • ◆H&Iグローバルリサーチのお客様（例）◆